Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)alkanoic acids active as novel dual-targeted PTP1B/AKR1B1 inhibitors
Rosanna Maccari(University of Messina), Rosaria Ottanà(University of Messina), Valerij Talagayev(Institute of Molecular Biology), Gemma Sardelli(University of Pisa), Paolo Paoli(University of Florence), Simone Luti(University of Florence), Antonella Del Corso(University of Pisa), Alice Santi(European Society for Sexual Medicine), Massimo Genovese(University of Florence), Francesco Balestri(University of Pisa), Gerhard Wolber(Research Institute for Pharmacy and Biochemistry (Czechia)), Roberta Moschini(University of Pisa)
Cited by 0
Related Papers
Morin: A Promising Natural Drug
|Current Medicinal Chemistry|2016|249
Cancer Associated Fibroblasts: The Architects of Stroma Remodeling
|PROTEOMICS|2017|247
Tumor matrix stiffness promotes metastatic cancer cell interaction with the endothelium
|The EMBO Journal|2017|201
<i>In silico</i>Target Fishing for Rationalized Ligand Discovery Exemplified on Constituents of<i>Ruta graveolens</i>
|Planta Medica|2008|141
The insulin-mimetic effect of Morin: A promising molecule in diabetes treatment
|Biochimica et Biophysica Acta (BBA) - General Subjects|2013|134